A careful comparison worksheet
A neutral framework for comparing ibogaine addiction clinics worldwide by the details that should be documented: screening, staffing, monitoring, emergency readiness, legal context, and follow-up.
Start with the record
Ibogaine is a psychoactive substance with important cardiac and medication-interaction concerns. The strongest first comparison is not a ranking of destinations; it is whether a program can plainly explain who it will not accept, what it checks beforehand, who is present during care, and what happens if a person deteriorates.
For a broader starting point on treatment questions, the Open Field 33 overview of ibogaine options can help place clinic claims in a cautious context. People weighing opioid-related care may also need to distinguish program language from evidence by reviewing ibogaine and opioid treatment considerations before treating any program description as a clinical recommendation.
The U.S. National Institute on Drug Abuse notes that substances can create health risks and that treatment decisions should be grounded in professional assessment; its overview of treatment for drug use and addiction is a useful reminder that medical risk assessment is not optional. A provider that avoids direct answers about exclusions, emergency equipment, or transfer pathways should not be made to fill those gaps with reassurance.
The intake bench
A comparison should ask whether pre-treatment screening includes an ECG, relevant laboratory testing, a medication reconciliation, and specific review of medicines that may affect cardiac rhythm or metabolism. In particular, ask how the program reviews CYP2D6-related medication issues and whether it uses documented exclusion or deferral criteria.
It is also reasonable to ask how a program handles withdrawal, co-occurring health conditions, pregnancy, recent substance use, and unstable housing or support. For terminology that can obscure a program’s actual process, compare the language used in the different names used for ibogaine with the concrete procedures the clinic says it follows.
Standardized comparison points
Ask which licensed clinicians are physically present, who makes escalation decisions, and whether credentials can be independently verified in the jurisdiction where care occurs. A claimed title is not the same as a documented role or scope of practice.
Ask what monitoring is continuous, how observations are recorded, how long monitoring continues, and what triggers a change in care. The U.S. Food and Drug Administration’s guidance on abnormal heart rhythms illustrates why QT-related risk and medication review deserve specific attention.
Ask whether a defibrillator and naloxone are immediately available, whether staff rehearse emergency response, and whether there is a written transfer arrangement with a higher-acuity facility. “Help nearby” is less useful than a documented plan.
Care is more than the dose
A program should be able to explain whether detoxification is separated from ibogaine dosing, how stabilization is assessed, and who supervises each phase. Combining distinct stages without explaining observation, medication management, and decision authority makes it difficult to compare the actual level of care.
Aftercare also needs a practical structure: what follow-up is offered, what happens after a return home, how urgent concerns are routed, and whether the program makes referrals when ongoing substance-use or mental-health care is needed. The U.S. ibogaine treatment center landscape may use different labels, but labels do not substitute for a written continuity plan.
Claims involving depression deserve equally careful separation from evidence and marketing. Compare a clinic’s language with the questions raised by ibogaine and depression resources and depression-focused ibogaine treatment discussions; neither a testimonial nor a destination should be treated as proof of an expected outcome.
Provenance & accountability
Legal status varies by country and region, and it can change. A prospective patient should ask which laws, licensing rules, import requirements, and clinical regulations the program says apply where care is offered. The general legal overview of ibogaine is only a starting point; it cannot confirm the current status of a specific provider or jurisdiction.
For Mexico-based options, distinguish a location claim from a verifiable operating framework. Resources discussing an ibogaine treatment facility in Mexico or an ibogaine clinic in Tijuana may help surface questions, but the program itself should provide current, specific answers about its protocols and emergency transfer arrangements.
Transparency has practical markers: published screening criteria, written monitoring procedures, a clear route for reporting concerns, and a candid account of what is not known. A careful review can also include the site’s safety and risk framework and the approach described in the organization’s stated principles when deciding which questions should remain non-negotiable.
“Anecdotes can be meaningful to the person telling them, but they are not a substitute for published procedures, independently verifiable credentials, or a documented emergency plan.”
Common comparison questions
Useful materials include screening and exclusion criteria, monitoring and escalation procedures, medication-management practices, an emergency plan, qualifications that can be independently verified, and a clear account of follow-up. A clinic should be able to distinguish documented protocol from promotional language.
No. Testimonials are anecdotal accounts. They may describe an individual’s experience, but they do not establish safety, clinical quality, or expected outcomes for another person. For the legal questions that can affect cross-border care, keep separate notes using the legal and ethics overview alongside a clinic’s own written statements.
Treat it as missing. Do not infer staffing levels, equipment, transfer capacity, or outcome quality from polished language. A program that cannot answer a focused question in writing has not supplied a comparable fact.
Use a consistent set of safety, governance, and transparency criteria for every program you consider. This resource does not recommend clinics or provide medical or legal advice.
Review the comparison approach